RnDCircle Logo
최영진 연구실
가톨릭대학교 의학과 최영진 교수
신장세포암
맞춤형 NGS 패널
생존특이 유전자
기본 정보
연구 분야
프로젝트
논문
구성원

최영진 연구실

가톨릭대학교 의학과 최영진 교수

최영진 연구실은 신장질환의 임상적 예측과 연구 인프라 구축을 연계해 수행합니다. 신장암에서는 맞춤형 NGS gene panel 기반으로 생존특이 유전자와 성별 특이 변이를 탐색하고, 임상-병리 지표와의 연관성을 검증하여 바이오마커로 정리합니다. 신장종양에서는 CT radiomics와 machine learning을 활용해 양성·악성 감별 예측 모델을 개발합니다. 또한 병리 확정 데이터 기반 역학 분석을 수행하고, ISO 20387에 부합하는 바이오뱅킹 교육 표준안을 제안하여 표본 품질과 운영역량을 보강합니다.

신장세포암맞춤형 NGS 패널생존특이 유전자성별 특이 변이CT radiomics
대표 연구 분야
연구 영역 전체보기
신장세포암 생존특이 유전자 서명 및 성별 특이 변이 예측 thumbnail
신장세포암 생존특이 유전자 서명 및 성별 특이 변이 예측
Survival-specific gene signatures and sex-specific mutation predictors in renal cell carcinoma
연구 분야 상세보기
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수

18총합

5개년 연도별 피인용 수

72총합
주요 논문
5
논문 전체보기
1
article
|
인용수 0
·
2025
A single-institution demographic study of pathologically proven kidney disease in South Korea over the last 33 years
Hyejin Noh, Ji Yeon Kim, Yeong Jin Choi
IF 3 (2025)
Journal of Pathology and Translational Medicine
BACKGROUND: To date, epidemiological studies on the entire spectrum of kidney disease based on pathology have been rarely reported. METHODS: A retrospective study was conducted on patients diagnosed with kidney disease at Seoul St. Mary's Hospital between 1991 and 2023. RESULTS: Among 7,803 patients with native kidney disease, glomerular disease (70.3%) was the most common, followed by tubulointerstitial (15.1%) and vascular disease (8.8%). In kidney biopsy, glomerular disease (77.8%) showed the highest frequency, particularly in those under 20s (95.6%) (p = .013). Primary glomerulonephritis (GN) (72.8%) was the predominant glomerular disease, with IgA nephropathy (IgAN) (47.3%) being the most common one. Tubulointerstitial and vascular diseases increased with age, showing the highest prevalence in those over 60 years (p = .008 and p = .032, respectively). Glomerular disease was diagnosed at a younger age (39.7 ± 16.7 years) than tubulointerstitial (49.1 ± 16.2) and vascular (48.1 ± 15.3) diseases (p < .001). When glomerular diseases were classified morphologically, proliferative GN (57.9%) was the most common, followed by non-proliferative (39.6%) and sclerosing (1.6%). When classified by etiology, primary GN accounted for the most (72.8%), followed by secondary (19.3%) and hereditary GN (5.7%). In nephrectomy, tubulointerstitial disease (64.6%) was the most common. Those with a tubulointerstitial disease had a higher mean age than those with a glomerular disease (p < .001). In cases where nephrectomy was performed for glomerular diseases, IgAN (34.1%) was the most common diagnosis. CONCLUSIONS: Kidney disease has been increasing in South Korea for 33 years. Glomerular disease was the most common across all age groups, tubulointerstitial and vascular diseases increased over 60 years.
https://doi.org/10.4132/jptm.2025.06.18
Kidney disease
Disease
Kidney
Epidemiology
Vascular disease
2
review
|
인용수 4
·
2025
Professional biobanking education in Korea based on ISO 20387
Jong Ok Kim, Chungyeul Kim, Sang‐Yong Song, Eunah Shin, Ji-Sun Song, Mee Sook Roh, Dong-Chul Kim, Han Kyeom Kim, Joon Mee Kim, Yeong Jin Choi
IF 3 (2025)
Journal of Pathology and Translational Medicine
To ensure high-quality bioresources and standardize biobanks, there is an urgent need to develop and disseminate educational training programs in accordance with ISO 20387, which was developed in 2018. The standardization of biobank education programs is also required to train biobank experts. The subdivision of categories and levels of education is necessary for jobs such as operations manager (bank president), quality manager, practitioner, and administrator. Essential training includes programs tailored for beginner, intermediate, and advanced practitioners, along with customized training for operations managers. We reviewed and studied ways to develop an appropriate range of education and training opportunities for standard biobanking education and the training of experts based on KS J ISO 20387. We propose more systematic and professional biobanking training programs in accordance with ISO 20387, in addition to the certification programs of the National Biobank and the Korean Laboratory Accreditation System. We suggest various training programs appropriate to a student's affiliation or work, such as university biobanking specialized education, short-term job training at unit biobanks, biobank research institute symposiums by the Korean Society of Pathologists, and education programs for biobankers and researchers. Through these various education programs, we expect that Korean biobanks will satisfy global standards, meet the needs of users and researchers, and contribute to the advancement of science.
https://doi.org/10.4132/jptm.2024.11.04
Biobank
Medicine
Medical education
Professional development
Professional association
Bioinformatics
Public relations
Political science
3
article
|
인용수 4
·
2024
Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma
Jia Hwang, Hye‐Eun Lee, Jin Han, Moon Hyung Choi, Sung‐Hoo Hong, Sae Woong Kim, Jihoon Yang, Unsang Park, Eun Sun Jung, Yeong Jin Choi
IF 3.9 (2024)
Scientific Reports
Although sex differences have been reported in patients with clear cell renal cell carcinoma (ccRCC), biological sex has not received clinical attention and genetic differences between sexes are poorly understood. This study aims to identify sex-specific gene mutations and explore their clinical significance in ccRCC. We used data from The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma (TCGA-KIRC), The Renal Cell Cancer-European Union (RECA-EU) and Korean-KIRC. A total of 68 sex-related genes were selected from TCGA-KIRC through machine learning, and 23 sex-specific genes were identified through verification using the three databases. Survival differences according to sex were identified in nine genes (ACSS3, ALG13, ASXL3, BAP1, JADE3, KDM5C, KDM6A, NCOR1P1, and ZNF449). Female-specific survival differences were found in BAP1 in overall survival (OS) (TCGA-KIRC, p = 0.004; RECA-EU, p = 0.002; and Korean-KIRC, p = 0.003) and disease-free survival (DFS) (TCGA-KIRC, p = 0.001 and Korean-KIRC, p = 0.000004), and NCOR1P1 in DFS (TCGA-KIRC, p = 0.046 and RECA-EU, p = 0.00003). Male-specific survival differences were found in ASXL3 (OS, p = 0.017 in TCGA-KIRC; and OS, p = 0.005 in RECA-EU) and KDM5C (OS, p = 0.009 in RECA-EU; and DFS, p = 0.016 in Korean-KIRC). These results suggest that biological sex may be an important predictor and sex-specific tailored treatment may improve patient care in ccRCC.
https://doi.org/10.1038/s41598-024-66525-9
Renal cell carcinoma
Gene
Clear cell renal cell carcinoma
Biology
Cell
Bioinformatics
Oncology
Internal medicine
Medicine
Cancer research
최신 정부 과제
1
과제 전체보기
1
주관|
2015년 10월-2018년 10월
|50,622,000
전이성 신세포암 환자에서 NGS 기반의 신장암 표적유전자패널 개발 및 약제민감도 스크리닝을 통한 개인맞춤치료 기반 구축
전이성 신장암 환자에서 NGS 기반의 “신장암 표적유전자패널”을 개발하여 임상 진단에 적용하는 것을 일차 목표로 함. “신장암 표적유전자패널” 제작을 위해 조직에서 유전자변이를 탐색, 발굴하는 NGS 기술을 확립하여 차세대 신장암 진단 및 맞춤치료의 기반을 구축하고자 함. 또한 전이암조직의 일차세포배양을 통한 약제민감도 스크리닝을 시행하여 부작용이 심한 면역치료제 및 표적치료제를 평가하는 것을 이차 목표로 함. 1) 한국인 재발 및 전이성 신장암 파라핀/신선 조직 확보 2) 파라핀 조직을 이용한 NGS 유전자 검사기법의 개발 3) NGS 의 결과 분석을 위한 생물정보학적 분석기법 개발 4) NGS 유전자 검사기법 및 생물정보학적 분석기법의 진단 적용 5) NGS 를 이용한 후보 유전자 변이 발굴 6) 발굴된 유전자 검증: direct sequencing을 이용 7) 발굴 유전자에 대한 임상검증 8) 한국인 난치성 신장암의 진단 활용 및 유전자변이 가이드라인 개발. 9) 한국인 난치성 신장암의 “신장암 표적유전자패널” 개발 및 치료에 활용. 10) 전이성 신장암에서 일차세포 배양기술 확립 및 약제민감도 스크리닝을 시행.
신세포암
전이성
파라핀조직
차세대 유전분석
일차세포배양
약제민감도 스크리닝
개인맞춤치료
최신 특허
특허 전체보기
상태출원연도과제명출원번호상세정보
거절2020연령에 따른 방광암의 예후 진단용 조성물 및 키트1020200037733
거절2020성별에 따른 방광암의 예후 진단용 조성물 및 키트1020200037734
거절2020유두형 신장암의 재발 및 예후 예측용 바이오 마커 및 이의 용도1020200019702
전체 특허

연령에 따른 방광암의 예후 진단용 조성물 및 키트

상태
거절
출원연도
2020
출원번호
1020200037733

성별에 따른 방광암의 예후 진단용 조성물 및 키트

상태
거절
출원연도
2020
출원번호
1020200037734

유두형 신장암의 재발 및 예후 예측용 바이오 마커 및 이의 용도

상태
거절
출원연도
2020
출원번호
1020200019702

주식회사 디써클

대표 장재우,이윤구서울특별시 강남구 역삼로 169, 명우빌딩 2층 (TIPS타운 S2)대표 전화 0507-1312-6417이메일 info@rndcircle.io사업자등록번호 458-87-03380호스팅제공자 구글 클라우드 플랫폼(GCP)

© 2026 RnDcircle. All Rights Reserved.